Colgate-Palmolive posted a higher profit in the first quarter but lowered 2025 earnings guidance due to tariffs.

Colgate-Palmolive on Friday reported better-than-expected first-quarter results and lifted its full-year sales outlook, ...

We look at Colgate-Palmolive Company's Q1 results, market challenges, and tariff impacts. Read to see if the CL stock is ...

Organic sales rose 1.4% during the quarter, with pricing up 1.5% and volume down 0.1%. The impact of FX was a negative 4.4% ...

Colgate-Palmolive surpassed earnings expectations in Q1 2025, despite experiencing a decline in overall sales.

EDT Colgate-Palmolive (CL) says to take prudent pricing to mitigate tariff impactStay Ahead of the Market: Discover outperforming stocks ...

Shares in consumer products group Colgate-Palmolive (CL) shone brightly in early trading today as it reported forecast beating first quarter ...

JP Morgan analyst Andrea Teixeira maintained an Overweight rating and slashed the price target from $99 to $95 on April 11, ...

Colgate-Palmolive (NYSE: CL) shares rose premarket after Q1 FY25 earnings beat expectations. Revenue hit $4.91B, topping estimates, with 1.4% organic sales growth and $0.91 EPS exceeding forecasts.

Investing.com - Colgate-Palmolive (NYSE: CL) has slashed its full-year guidance for organic sales, becoming the latest ...

Higher costs could further dampen consumer demand. For Colgate, tariffs will drive raw and packaging materials costs higher ...

Dan Loeb’s Third Point Capital has built a stake in Tylenol and Neutrogena maker Kenvue, becoming the third activist hedge ...